Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 16, Issue 7, Pages 1056-1070
Publisher
Informa UK Limited
Online
2015-05-12
DOI
10.1080/15384047.2015.1046023
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cinobufacin Suppresses Cell Proliferation via miR-494 in BGC-823 Gastric Cancer Cells
- (2014) Rong-Ping Zhou et al. Asian Pacific Journal of Cancer Prevention
- Hinokitiol Induces DNA Damage and Autophagy followed by Cell Cycle Arrest and Senescence in Gefitinib-Resistant Lung Adenocarcinoma Cells
- (2014) Lan-Hui Li et al. PLoS One
- Doxorubicin, DNA torsion, and chromatin dynamics
- (2013) Fan Yang et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions
- (2013) Sheng-Da Hsu et al. NUCLEIC ACIDS RESEARCH
- The role of p21waf1/cip1 and p27Kip1 in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma
- (2013) A Newbold et al. ONCOGENE
- miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A
- (2012) X. Zhu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Increased Expression of P-Glycoprotein and Doxorubicin Chemoresistance of Metastatic Breast Cancer Is Regulated by miR-298
- (2012) Lili Bao et al. AMERICAN JOURNAL OF PATHOLOGY
- Antagonism between curcumin and the topoisomerase II inhibitor etoposide
- (2012) Ekram M. Saleh et al. CANCER BIOLOGY & THERAPY
- Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non-Small Cell Lung Cancers
- (2012) G. Heller et al. CLINICAL CANCER RESEARCH
- Highly Synergistic Effect of Sequential Treatment with Epigenetic and Anticancer Drugs To Overcome Drug Resistance in Breast Cancer Cells Is Mediated via Activation of p21 Gene Expression Leading to G2/M Cycle Arrest
- (2012) Sivakumar Vijayaraghavalu et al. MOLECULAR PHARMACEUTICS
- MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation
- (2012) G. Romano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-125b Induces Cancer Cell Apoptosis Through Suppression of Bcl-2 Expression
- (2011) Aihua Zhao et al. Journal of Genetics and Genomics
- Interaction of celecoxib with different anti-cancer drugs is antagonistic in breast but not in other cancer cells
- (2011) Raafat A. El-Awady et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
- (2010) Alex Chang LUNG CANCER
- MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8
- (2010) L Fang et al. ONCOGENE
- Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes
- (2008) A M Calcagno et al. BRITISH JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now